{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:28:47Z","timestamp":1783484927111,"version":"3.55.0"},"reference-count":25,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2012]]},"DOI":"10.2169\/internalmedicine.51.7845","type":"journal-article","created":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T22:40:50Z","timestamp":1344897650000},"page":"2189-2192","source":"Crossref","is-referenced-by-count":26,"title":["Sudden Onset Agranulocytosis and Hepatotoxicity after Taking Methimazole"],"prefix":"10.2169","volume":"51","author":[{"given":"Jing","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Metabolism & Endocrinology of the First Affiliated Hospital, University of South China, China"},{"name":"Department of Pathophysiology, University of South China, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhong","sequence":"additional","affiliation":[{"name":"Clinical Medical Research Institute of the First Affiliated Hospital, University of South China, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Zhi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Clinical Medical Research Institute of the First Affiliated Hospital, University of South China, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Metabolism & Endocrinology of the First Affiliated Hospital, University of South China, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Hua","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Metabolism & Endocrinology of the First Affiliated Hospital, University of South China, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge-Bo","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Metabolism & Endocrinology of the First Affiliated Hospital, University of South China, China"},{"name":"Clinical Medical Research Institute of the First Affiliated Hospital, University of South China, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. He CT, Hsieh AT, Pei D, et al. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism. Clin Endocrinol (Oxf) 60: 676-681, 2004.","DOI":"10.1111\/j.1365-2265.2004.02032.x"},{"key":"2","unstructured":"2. Emiliano AB, Governale L, Parks M, Cooper DS. Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008. J Clin Endocrinol Metab 95: 2227-2233, 2010."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cooper DS. Antithyroid drugs. N Engl J Med 352: 905-917, 2005.","DOI":"10.1056\/NEJMra042972"},{"key":"4","unstructured":"4. Tajiri J, Noguchi S. Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis. Thyroid 14: 459-462, 2004."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Woeber KA. Methimazole-induced hepatotoxicity. Endocr Pract 8: 222-224, 2002.","DOI":"10.4158\/EP.8.3.222"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Vilchez FJ, Torres I, Garcia-Valero A, Lopez-Tinoco C, de Los Santos A, Aguilar-Diosdado M. Concomitant agranulocytosis and hepatotoxicity after treatment with carbimazole. Ann Pharmacother 40: 2059-2063, 2006.","DOI":"10.1345\/aph.1G720"},{"key":"7","unstructured":"7. Jain K, Chakrapani M, Smitha K. Acute cholestatic hepatitis along with agranulocytosis: a rare side effect of carbimazole. Ann Afr Med 9: 102-104, 2010."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Takata K, Kubota S, Fukata S, et al. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. Thyroid 19: 559-563, 2009.","DOI":"10.1089\/thy.2008.0364"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Waldhauser L, Uetrecht J. Oxidation of propylthiouracil to reactive metabolites by activated neutrophils. Implications for agranulocytosis. Drug Metab Dispos 19: 354-359, 1991.","DOI":"10.1016\/S0090-9556(25)07126-0"},{"key":"10","unstructured":"10. Pisciotta AV. Immune and toxic mechanisms in drug-induced agranulocytosis. Semin Hematol 10: 279-310, 1973."},{"key":"11","unstructured":"11. Meyer-Gessner M, Benker G, Lederbogen S, Olbricht T, Reinwein D. Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature. J Endocrinol Invest 17: 29-36, 1994."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Cooper DS, Goldminz D, Levin AA, et al. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med 98: 26-29, 1983.","DOI":"10.7326\/0003-4819-98-1-26"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tsuboi K, Ueshiba H, Shimojo M, et al. The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves' disease. Endocr J 54: 39-43, 2007.","DOI":"10.1507\/endocrj.K05-068"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sun MT, Tsai CH, Shih KC. Antithyroid drug-induced agranulocytosis. J Chin Med Assoc 72: 438-441, 2009.","DOI":"10.1016\/S1726-4901(09)70402-2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Andres E, Zimmer J, Mecili M, Weitten T, Alt M, Maloisel F. Clinical presentation and management of drug-induced agranulocytosis. Expert Rev Hematol 4: 143-151, 2011.","DOI":"10.1586\/ehm.11.12"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Apinantriyo B, Lekhakula A, Rujirojindakul P. Incidence, etiology and bone marrow characteristics of non-chemotherapy-induced agranulocytosis. Hematology 16: 50-53, 2011.","DOI":"10.1179\/102453311X12902908411715"},{"key":"17","unstructured":"17. Douer D, Eisenstein Z. Methimazole-induced agranulocytosis: growth inhibition of myeloid progenitor cells by the patient's serum. Eur J Haematol 40: 91-94, 1988."},{"key":"18","unstructured":"18. Akamizu T, Ozaki S, Hiratani H, et al. Drug-induced neutropenia associated with anti-neutrophil cytoplasmic antibodies (ANCA): possible involvement of complement in granulocyte cytotoxicity. Clin Exp Immunol 127: 92-98, 2002."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sera N, Ashizawa K, Ando T, et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Thyroid 10: 595-599, 2000.","DOI":"10.1089\/thy.2000.10.595"},{"key":"20","unstructured":"20. Wall JR, Fang SL, Kuroki T, Ingbar SH, Braverman LE. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis. J Clin Endocrinol Metab 58: 868-872, 1984."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ruiz JK, Rossi GV, Vallejos HA, Brenet RW, Lopez IB, Escribano AA. Fulminant hepatic failure associated with propylthiouracil. Ann Pharmacother 37: 224-228, 2003.","DOI":"10.1345\/aph.1A408"},{"key":"22","unstructured":"22. Livadas S, Xyrafis X, Economou F, et al. Liver failure due to antithyroid drugs: report of a case and literature review. Endocrine 38: 24-28, 2010."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Arab DM, Malatjalian DA, Rittmaster RS. Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole. J Clin Endocrinol Metab 80: 1083-1085, 1995.","DOI":"10.1210\/jc.80.4.1083"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Hanson JS. Propylthiouracil and hepatitis. Two cases and a review of the literature. Arch Intern Med 144: 994-996, 1984.","DOI":"10.1001\/archinte.1984.00350170148025"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Gallelli L, Staltari O, Palleria C, De Sarro G, Ferraro M. Hepatotoxicity induced by methimazole in a previously healthy patient. Curr Drug Saf 4: 204-206, 2009.","DOI":"10.2174\/157488609789006912"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/51\/16\/51_51.7845\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T21:19:28Z","timestamp":1743974368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/51\/16\/51_51.7845\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":25,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.51.7845","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}